Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study
- DOI
- 10.1016/j.ard.2026.09.022
- Published
- 2026-10
- Container
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ard.2026.09.022,
title = {Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study},
author = {Sabine A Eming and Alexander Kreuter and Matthias Hahn and Kamran Ghoreschi and Pia Moinzadeh and Nicolas Hunzelmann and Kerstin Becker and Nils Reiche and Anne Adams and Kija Shah-Hosseini and Martin Hellmich and Sebastian Willenborg and David E Sanin and Martin Röcken and Thomas Krieg},
year = {2026},
journal = {Annals of the Rheumatic Diseases},
doi = {10.1016/j.ard.2026.09.022},
url = {https://doi.org/10.1016/j.ard.2026.09.022}
}RIS
TY - JOUR TI - Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study AU - Sabine A Eming AU - Alexander Kreuter AU - Matthias Hahn AU - Kamran Ghoreschi AU - Pia Moinzadeh AU - Nicolas Hunzelmann AU - Kerstin Becker AU - Nils Reiche AU - Anne Adams AU - Kija Shah-Hosseini AU - Martin Hellmich AU - Sebastian Willenborg AU - David E Sanin AU - Martin Röcken AU - Thomas Krieg PY - 2026 JO - Annals of the Rheumatic Diseases DO - 10.1016/j.ard.2026.09.022 UR - https://doi.org/10.1016/j.ard.2026.09.022 ER -
APA
Eming, S. A., Kreuter, A., Hahn, M., Ghoreschi, K., Moinzadeh, P., Hunzelmann, N., Becker, K., Reiche, N., Adams, A., Shah-Hosseini, K., Hellmich, M., Willenborg, S., Sanin, D. E., Röcken, M., & Krieg, T. (2026). Interleukin 4-receptor-α blockade in localised scleroderma: a phase 2 proof-of-concept study. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.09.022
Source records
- crossref · retrieved 2026-11-10T13:31:43.141Z